Hyman Charles D Acquires 13,306 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Hyman Charles D grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 36.8% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 49,507 shares of the medical equipment provider’s stock after buying an additional 13,306 shares during the period. Intuitive Surgical makes up 1.2% of Hyman Charles D’s investment portfolio, making the stock its 25th largest holding. Hyman Charles D’s holdings in Intuitive Surgical were worth $22,023,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. Creekmur Asset Management LLC grew its holdings in Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 42 shares during the period. Delos Wealth Advisors LLC grew its stake in shares of Intuitive Surgical by 380.0% in the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 57 shares during the period. LRI Investments LLC bought a new stake in Intuitive Surgical in the 1st quarter valued at about $30,000. Able Wealth Management LLC bought a new position in Intuitive Surgical in the fourth quarter worth approximately $28,000. Finally, MeadowBrook Investment Advisors LLC acquired a new stake in Intuitive Surgical in the fourth quarter valued at approximately $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 1.5 %

Shares of ISRG stock traded down $7.36 during trading hours on Monday, hitting $479.19. 1,169,804 shares of the company were exchanged, compared to its average volume of 1,534,675. The stock has a market capitalization of $169.97 billion, a price-to-earnings ratio of 86.50, a P/E/G ratio of 4.97 and a beta of 1.39. The firm has a fifty day simple moving average of $450.50 and a 200 day simple moving average of $412.03. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $493.97.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.24. The firm had revenue of $2.01 billion for the quarter, compared to analyst estimates of $1.97 billion. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The business’s revenue was up 14.5% on a year-over-year basis. During the same period in the previous year, the company posted $1.18 earnings per share. Sell-side analysts anticipate that Intuitive Surgical, Inc. will post 5.22 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Henry L. Charlton sold 40,243 shares of Intuitive Surgical stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $486.84, for a total value of $19,591,902.12. Following the completion of the transaction, the senior vice president now owns 3,001 shares in the company, valued at $1,461,006.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, SVP Henry L. Charlton sold 40,243 shares of Intuitive Surgical stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the completion of the transaction, the senior vice president now directly owns 3,001 shares in the company, valued at $1,461,006.84. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Craig H. Barratt sold 2,496 shares of the firm’s stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $402.89, for a total value of $1,005,613.44. The disclosure for this sale can be found here. Insiders have sold a total of 55,948 shares of company stock valued at $26,427,177 over the last three months. 0.90% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of brokerages recently issued reports on ISRG. Robert W. Baird increased their target price on Intuitive Surgical from $487.00 to $503.00 and gave the stock an “outperform” rating in a report on Friday, July 19th. The Goldman Sachs Group assumed coverage on shares of Intuitive Surgical in a research report on Thursday, May 30th. They set a “buy” rating and a $500.00 target price for the company. Stifel Nicolaus raised their price target on shares of Intuitive Surgical from $430.00 to $475.00 and gave the company a “buy” rating in a research report on Friday, July 19th. BTIG Research boosted their price objective on Intuitive Surgical from $451.00 to $459.00 and gave the stock a “buy” rating in a report on Monday, July 15th. Finally, Morgan Stanley increased their price objective on Intuitive Surgical from $375.00 to $460.00 and gave the stock an “equal weight” rating in a research note on Monday, July 15th. Six equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $444.70.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.